Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GPE | Ann: Issued Units Outstanding as at 30 April 2024 | 06/05/24 | 0 | 94 | |||
|
|||||||
GPE | Ann: Issued Units Outstanding as at 31 March 2024 | 03/04/24 | 0 | 93 | |||
|
|||||||
GPE | Ann: Half-Year Financial Report | 14/03/24 | 0 | 105 | |||
|
|||||||
GPE | Ann: Indicative dividends calendar for 2024 | 05/03/24 | 0 | 113 | |||
|
|||||||
GPE | Ann: Issued Units Outstanding as at 29 February 2024 | 05/03/24 | 0 | 114 | |||
|
|||||||
GPE | Ann: Issued Units Outstanding as at 31 January 2024 | 02/02/24 | 0 | 86 | |||
|
|||||||
GPE | Ann: Issued Units Outstanding as at 31 December 2023 | 02/01/24 | 0 | 105 | |||
|
|||||||
GPE | Ann: Issued Units Outstanding as at 30 November 2023 | 05/12/23 | 0 | 99 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |